In this article, the authors look at the limitations of the validation for a single-use shipping system and provide a perspective on what shipping validation means.
As the biotech industry evolves, there are mounting concerns about the transportation, security, and robustness of cell-culture media, intermediate, or bulk drug substance (BDS). Safe, stable, and closed systems are needed when sterile products are shipped in single-use bags. In this article, the authors look at the limitations of the validation for a single-use shipping system and provide a perspective on what shipping validation means.
Download
Pharmaceutical Technology’s 2016 Bioprocessing and Sterile Manufacturing eBook.